$VXRT
Vaxart, Inc.

2015 Q1 Form 10-Q Financial Statement

#000143774915009555 Filed on May 08, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $5.900M $29.50M
YoY Change -80.0% 136.0%
Cost Of Revenue $4.800M $26.30M
YoY Change -81.75% 541.46%
Gross Profit $1.100M $3.200M
YoY Change -65.63% -61.9%
Gross Profit Margin 18.64% 10.85%
Selling, General & Admin $3.200M $2.500M
YoY Change 28.0% 19.05%
% of Gross Profit 290.91% 78.13%
Research & Development $4.800M $4.100M
YoY Change 17.07% -8.89%
% of Gross Profit 436.36% 128.13%
Depreciation & Amortization $300.0K $400.0K
YoY Change -25.0% -53.49%
% of Gross Profit 27.27% 12.5%
Operating Expenses $4.800M $4.100M
YoY Change 17.07% -37.88%
Operating Profit $1.100M $3.200M
YoY Change -65.63% 77.78%
Interest Expense $100.0K -$400.0K
YoY Change -125.0% 33.33%
% of Operating Profit 9.09% -12.5%
Other Income/Expense, Net $100.0K $0.00
YoY Change
Pretax Income $1.200M $3.200M
YoY Change -62.5% 1500.0%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $1.200M $3.200M
YoY Change -62.5% 1500.0%
Net Earnings / Revenue 20.34% 10.85%
Basic Earnings Per Share $0.02 $0.09
Diluted Earnings Per Share $0.02 $0.09
COMMON SHARES
Basic Shares Outstanding 35.11M 33.89M
Diluted Shares Outstanding 35.14M 34.26M

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $73.50M $80.10M
YoY Change -8.24% 13.94%
Cash & Equivalents $61.50M $80.10M
Short-Term Investments $12.00M
Other Short-Term Assets $900.0K $900.0K
YoY Change 0.0% -50.0%
Inventory
Prepaid Expenses
Receivables $10.10M $36.50M
Other Receivables $0.00 $0.00
Total Short-Term Assets $87.40M $117.5M
YoY Change -25.62% 34.59%
LONG-TERM ASSETS
Property, Plant & Equipment $300.0K $2.800M
YoY Change -89.29% -33.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $900.0K
YoY Change
Other Assets $200.0K
YoY Change
Total Long-Term Assets $1.400M $3.000M
YoY Change -53.33% -60.0%
TOTAL ASSETS
Total Short-Term Assets $87.40M $117.5M
Total Long-Term Assets $1.400M $3.000M
Total Assets $88.80M $120.5M
YoY Change -26.31% 27.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.000M $7.300M
YoY Change -86.3% 217.39%
Accrued Expenses $4.500M $17.00M
YoY Change -73.53% 63.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.200M $24.30M
YoY Change -70.37% 68.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $100.0K $200.0K
YoY Change -50.0% -33.33%
Total Long-Term Liabilities $100.0K $200.0K
YoY Change -50.0% -33.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.200M $24.30M
Total Long-Term Liabilities $100.0K $200.0K
Total Liabilities $7.300M $24.50M
YoY Change -70.2% 66.67%
SHAREHOLDERS EQUITY
Retained Earnings -$89.00M
YoY Change
Common Stock $151.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $81.50M $96.00M
YoY Change
Total Liabilities & Shareholders Equity $88.80M $120.5M
YoY Change -26.31% 27.11%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income $1.200M $3.200M
YoY Change -62.5% 1500.0%
Depreciation, Depletion And Amortization $300.0K $400.0K
YoY Change -25.0% -53.49%
Cash From Operating Activities $800.0K $700.0K
YoY Change 14.29% -119.13%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K -$100.0K
YoY Change 0.0% 11.11%
Acquisitions
YoY Change
Other Investing Activities $400.0K
YoY Change
Cash From Investing Activities $300.0K -$100.0K
YoY Change -400.0% 25.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 26.80M
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 800.0K 700.0K
Cash From Investing Activities 300.0K -100.0K
Cash From Financing Activities 0.000 26.80M
Net Change In Cash 1.100M 27.40M
YoY Change -95.99% -832.62%
FREE CASH FLOW
Cash From Operating Activities $800.0K $700.0K
Capital Expenditures -$100.0K -$100.0K
Free Cash Flow $900.0K $800.0K
YoY Change 12.5% -122.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 bota Accrued Liabilities Clinical Preclinical And Manufacturing
AccruedLiabilitiesClinicalPreclinicalAndManufacturing
1600000
CY2014Q2 bota Accrued Liabilities Clinical Preclinical And Manufacturing
AccruedLiabilitiesClinicalPreclinicalAndManufacturing
800000
CY2015Q1 bota Dilutive Effect Of Restricted Stock And Stock Options
DilutiveEffectOfRestrictedStockAndStockOptions
37200
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10100000
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
900000
CY2015Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
-100000
CY2014Q1 bota Dilutive Effect Of Restricted Stock And Stock Options
DilutiveEffectOfRestrictedStockAndStockOptions
370245
bota Dilutive Effect Of Restricted Stock And Stock Options
DilutiveEffectOfRestrictedStockAndStockOptions
24404
bota Increase Decrease Accrued Severance Obligations
IncreaseDecreaseAccruedSeveranceObligations
-1700000
bota Increase Decrease Accrued Severance Obligations
IncreaseDecreaseAccruedSeveranceObligations
-2200000
CY2015Q1 bota Severance Obligations Accrued
SeveranceObligationsAccrued
400000
CY2014Q2 bota Severance Obligations Accrued
SeveranceObligationsAccrued
1200000
CY2015Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1100000
CY2014Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
18600000
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1000000
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2800000
CY2015Q1 us-gaap Accounts Receivable Billed For Long Term Contracts Or Programs
AccountsReceivableBilledForLongTermContractsOrPrograms
2900000
CY2014Q2 us-gaap Accounts Receivable Billed For Long Term Contracts Or Programs
AccountsReceivableBilledForLongTermContractsOrPrograms
17800000
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4500000
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3400000
CY2015Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
900000
CY2014Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1000000
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
19000000
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
26800000
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
148000000
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
146400000
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
600000
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1600000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1400000
CY2015Q1 us-gaap Assets
Assets
88800000
CY2014Q2 us-gaap Assets
Assets
114000000
CY2015Q1 us-gaap Assets Current
AssetsCurrent
87400000
CY2014Q2 us-gaap Assets Current
AssetsCurrent
101100000
CY2015Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
1400000
CY2014Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
12900000
CY2015Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
34100000
CY2014Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
46900000
CY2015Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
34100000
CY2014Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
46900000
CY2015Q1 us-gaap Available For Sale Securities Short Term Investments Amortized Cost
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCost
34200000
CY2014Q2 us-gaap Available For Sale Securities Short Term Investments Amortized Cost
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCost
46900000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61500000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81700000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66800000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80100000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-12500000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12700000
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7000000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-200000
CY2015Q1 us-gaap Cost Of Services
CostOfServices
300000
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000000000
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000000000
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35124728000000
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35100961000000
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35124728000000
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35100961000000
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
3500000
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
3500000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1500000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4500000
CY2014Q1 us-gaap Cost Of Services
CostOfServices
19300000
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7200000
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
26900000
CY2015Q1 us-gaap Long Term Investments
LongTermInvestments
900000
CY2014Q2 us-gaap Long Term Investments
LongTermInvestments
10000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26800000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2700000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-200000
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3200000
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2500000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8200000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8000000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1200000
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3200000
us-gaap Cost Of Services
CostOfServices
3600000
us-gaap Cost Of Services
CostOfServices
41400000
CY2015Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
200000
CY2014Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
900000
CY2015Q1 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
200000
CY2014Q2 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
900000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1100000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1400000
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-7700000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
600000
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1500000
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
400000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2014Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2015Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4100000
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2014Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2015Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2015Q1 us-gaap Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions
0
CY2015Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3700000
CY2014Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-400000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
6500000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-600000
CY2015Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-200000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-200000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
800000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-900000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-17400000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10500000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5800000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25300000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-200000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
200000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1300000
CY2015Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
100000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
300000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
100000
CY2015Q1 us-gaap Liabilities
Liabilities
7300000
CY2014Q2 us-gaap Liabilities
Liabilities
27100000
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
88800000
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114000000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9800000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13900000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
1200000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
3200000
us-gaap Net Income Loss
NetIncomeLoss
800000
CY2014Q1 us-gaap Revenues
Revenues
29500000
us-gaap Revenues
Revenues
20500000
us-gaap Net Income Loss
NetIncomeLoss
-800000
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
100000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
300000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
100000
CY2015Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4800000
CY2014Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
26300000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
20000000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
61300000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1100000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3200000
us-gaap Operating Income Loss
OperatingIncomeLoss
500000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1000000
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
500000
CY2014Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1200000
CY2015Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2700000
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1300000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7700000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
600000
CY2015Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
100000
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
200000
us-gaap Other Operating Income
OtherOperatingIncome
100000
CY2015Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
300000
us-gaap Payments For Restructuring
PaymentsForRestructuring
1600000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
9900000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
100000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
200000
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
900000
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
700000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26800000
us-gaap Proceeds From Maturities Prepayments And Calls Of Longterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments
6900000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
400000
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
300000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2000000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4800000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4100000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14500000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11300000
us-gaap Restructuring Charges
RestructuringCharges
300000
CY2014Q2 us-gaap Restructuring Reserve
RestructuringReserve
2000000
CY2015Q1 us-gaap Restructuring Reserve
RestructuringReserve
700000
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89000000
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89800000
us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
100000
CY2015Q1 us-gaap Revenues
Revenues
5900000
us-gaap Revenues
Revenues
60300000
CY2015Q1 us-gaap Royalty Revenue
RoyaltyRevenue
5500000
CY2014Q1 us-gaap Royalty Revenue
RoyaltyRevenue
8100000
us-gaap Royalty Revenue
RoyaltyRevenue
12000000
us-gaap Royalty Revenue
RoyaltyRevenue
14100000
CY2015Q1 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
400000
CY2014Q1 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
21400000
us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
8400000
us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
46100000
CY2015Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
400000
CY2014Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
21400000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
8500000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
46100000
us-gaap Share Based Compensation
ShareBasedCompensation
1600000
us-gaap Share Based Compensation
ShareBasedCompensation
1400000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.012
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.016
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.015
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.0078
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34260715
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35127013
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.0078
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.0082
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30127156
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35105978
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33890470
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35102609
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30127156
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.0078
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
447777
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1355000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.59
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.22
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.67
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.12
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2463369
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3370592
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.09
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.30
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.44
CY2015Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1145063
CY2015Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
3370592
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y29D
CY2015Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
12.74
CY2015Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
6.30
CY2015Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P8Y29D
CY2015Q1 us-gaap Short Term Investments
ShortTermInvestments
12000000
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
81500000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
86900000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-100000
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35143178

Files In Submission

Name View Source Status
0001437749-15-009555-index-headers.html Edgar Link pending
0001437749-15-009555-index.html Edgar Link pending
0001437749-15-009555.txt Edgar Link pending
0001437749-15-009555-xbrl.zip Edgar Link pending
bota-20150331.xml Edgar Link completed
bota-20150331.xsd Edgar Link pending
bota-20150331_cal.xml Edgar Link unprocessable
bota-20150331_def.xml Edgar Link unprocessable
bota-20150331_lab.xml Edgar Link unprocessable
bota-20150331_pre.xml Edgar Link unprocessable
bota20150331_10q.htm Edgar Link pending
ex2-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending